LexaGene Holdings
Beverly
About LexaGene Holdings
LexaGene is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, food safety, and for use in open-access markets such as clinical research, agricultural testing, and biodefense. End-users simply need to collect a sample, load it onto the MiQLab™ system with a sample preparation cartridge, enter sample ID and press ‘go’. The MiQLab system delivers excellent sensitivity, specificity, and breadth of detection and can return results in quickly. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2019)
- Ticker: otcqb:LXXGF
- Website: lexagene.com
- Phone: +1 800 215 1824
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/lexagene-holdings-2225699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.